The global vascular imaging market, valued at US$3.03 billion in 2024, increased to US$3.19 billion in 2025 and is projected to grow at a robust CAGR of 7.3% from 2025 to 2030. This strong momentum is expected to push the market to US$4.54 billion by 2030, driven by a combination of increasing cardiovascular disease prevalence, advancements in imaging technologies, and greater adoption of minimally invasive diagnostic and therapeutic procedures.
Market Overview
Cardiovascular diseases remain the world’s leading cause of mortality, with rising cases of peripheral artery disease, coronary artery disease, aneurysms, and stroke. The increasing global burden of these conditions—fueled by lifestyle-related risk factors such as smoking, obesity, hypertension, diabetes, and sedentary habits—continues to be the primary force accelerating market growth. As clinicians rely heavily on imaging for early diagnosis, treatment planning, and surgical navigation, the demand for high-quality vascular imaging modalities is rising across hospitals and diagnostic centers.
Another major driver is the integration of digital, cloud, and AI-powered imaging solutions. Healthcare providers are increasingly adopting centralized image management systems, teleradiology platforms, and automated analysis tools to improve diagnostic accuracy and streamline workflows. Government initiatives promoting early disease detection, improved healthcare infrastructure, and enhanced reimbursement for imaging procedures further support the market’s expansion.
Key players leading technological innovation include Philips Healthcare (Netherlands), GE HealthCare (US), Siemens Healthineers (Germany), and FUJIFILM (Japan).
Market Segmentation
By Product Type
The vascular imaging market is segmented into:
- Systems & Consoles
- Accessories & Consumables
- Software & Services
Systems & Consoles Lead the Market
In 2024, systems and consoles dominated the global vascular imaging market. These platforms serve as the foundational infrastructure for high-performance imaging modalities, including:
- Ultrasound
- CT (Computed Tomography)
- MRI (Magnetic Resonance Imaging)
- Hybrid and advanced angiography systems
Their ability to produce high-resolution, real-time visualization of vascular structures makes them indispensable for clinicians diagnosing complex cardiovascular and peripheral vascular conditions.
As hospitals and surgical centers increasingly adopt multi-modality imaging systems, investments in advanced consoles continue to grow. AI-driven features, automated vessel analysis, and integrated workflow solutions—such as cloud connectivity and predictive analytics—further reinforce the leadership of this product segment.
By Application
The vascular imaging market encompasses a broad range of clinical applications:
- Atherosclerosis
- Aneurysms
- Vasculitis
- Deep vein thrombosis (DVT)
- Arteriovenous malformations (AVMs) and fistulas
- Other vascular disorders
Vasculitis Segment to Witness the Highest CAGR
Among these, the vasculitis segment is anticipated to record the fastest growth rate during the forecast period. Growing awareness of inflammatory vascular diseases, rising autoimmune disorders, and the need for precise evaluation of small- and large-vessel involvement are major contributors.
Technological advancements in:
- PET-CT
- MRI angiography (MRA)
- High-resolution duplex ultrasound
…have significantly enhanced early detection, biomarker-based monitoring, and treatment planning. As personalized medicine and targeted biologics evolve, demand for imaging tools that support disease staging and therapy tracking is expected to grow substantially.
By Geography
The global vascular imaging market is categorized into:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
- GCC Countries
Asia Pacific: Fastest Growing Regional Market
The Asia Pacific region is projected to experience the most significant growth from 2025 to 2030. Several factors contribute to this trend:
- Rapid expansion of healthcare infrastructure
- Increasing investment from key manufacturers in regional manufacturing and R&D
- Growing burden of chronic cardiovascular and metabolic diseases
- Rising demand for early, accurate diagnostic technologies
- Favorable government policies and screening programs
- A large and aging population
Countries such as China, India, South Korea, and Japan are accelerating adoption of advanced imaging systems, particularly high-resolution CT/MRI and AI-enabled ultrasound systems.
Competitive Landscape
As of 2024, leading companies in the vascular imaging market include:
- Siemens Healthineers (Germany)
- GE HealthCare (US)
- Philips Healthcare (Netherlands)
- FUJIFILM Corporation (Japan)
These players dominate due to their global reach, robust product portfolios, and strong focus on innovation.
Company Profiles
Siemens Healthineers (Germany)
Siemens Healthineers maintains a strong leadership position with a comprehensive suite of vascular imaging technologies designed to support precision diagnostics and minimally invasive interventions. Key technologies include:
- SOMATOM CT scanners
- MAGNETOM MRI systems
- Artis angiography systems
The company’s advanced platforms—AI-Rad Companion and syngo.via—leverage AI for:
- Automated vessel segmentation
- Plaque characterization
- 3D and 4D visualization
- Workflow automation
Siemens’ integration of digital ecosystems, including the teamplay cloud platform, enhances data-driven decision-making, elevating diagnostic accuracy and enabling personalized vascular care.
GE HealthCare (US)
GE HealthCare plays a critical role in delivering advanced imaging solutions, with a broad portfolio that includes:
- Revolution CT
- LOGIQ E10 ultrasound
- SIGNA MRI systems
These platforms support high-resolution vascular imaging, enabling detection of arterial blockages, venous abnormalities, and microvascular changes. GE’s Edison AI platform powers automated vessel analysis, advanced reconstruction, and diagnostic insights based on real-time data processing.
The company’s commitment to cloud-based interoperability, precision imaging, and cardiovascular care pathways solidifies its influence in the global market.
Philips Healthcare (Netherlands)
Philips Healthcare is recognized for its integrated imaging ecosystems and real-time vascular visualization capabilities. Its flagship products include:
- Azurion image-guided therapy platform
- Ingenia MRI systems
- IQon Spectral CT
- IntelliSpace Portal for 3D/4D advanced visualization
Philips’ Precision Diagnosis ecosystem, powered by AI and automation, supports accurate vessel quantification, plaque evaluation, and image-guided minimally invasive procedures. Its focus on interoperability and cloud-based data sharing through HealthSuite enhances workflow efficiency and elevates the quality of vascular care.
Conclusion
The vascular imaging market is entering a dynamic phase of innovation, driven by the escalating burden of cardiovascular diseases, rapid technological advancements, and expanding global healthcare access. As AI, cloud connectivity, and multi-modality platforms continue to redefine imaging workflows, major players like Siemens Healthineers, GE HealthCare, and Philips Healthcare are poised to strengthen their leadership.
For stakeholders—including device manufacturers, hospitals, imaging centers, and investors—the next five years represent a high-potential window to capitalize on the growing need for accurate, early vascular diagnostics and minimally invasive interventions.